Abeona Therapeutics Aktie 28637123 / US00289Y1073
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
11.11.2025 05:19:36
|
KalVista, Health Catalyst, Bio-Techne Lead After-Hours Gains On Earnings Updates
(RTTNews) - Several healthcare and biotech stocks posted notable gains in Monday's after-hours trading following earnings updates and guidance revisions.
KalVista Pharmaceuticals Inc. (KALV) rose 11.29% to $12.12 after hours, building on a modest 1.02% gain at the close. The company reported a third-quarter net loss of $49.5 million, or $0.92 per share, compared to a loss of $39.1 million, or $0.84 per share, in the same period last year. Net product revenue for the quarter reached $13.7 million.
Health Catalyst Inc. (HCAT) advanced 13.24% to $3.23 after hours, following a 0.71% increase during regular trading. The company posted a third-quarter net loss of $22.2 million, or $0.32 per share, versus $14.7 million, or $0.24 per share, a year ago. Revenue declined to $76.3 million from $86.4 million.
For Q4 2025, the company projects revenue of about $73.5 million and adjusted EBITDA of $13.4 million. Full-year expectations stand at $310 million in revenue and $41 million in adjusted EBITDA.
Bio-Techne Corp. (TECH) climbed 8.72% to $62.47 in after-hours trading. No new announcements were made on Monday, but the company recently reported first-quarter GAAP EPS of $0.24, up from $0.21 last year. Adjusted EPS remained flat at $0.42. Revenue declined 1% year-over-year to $286.6 million.
Assertio Holdings Inc. (ASRT) gained 8.30% to $0.87 after hours, adding to a 5.33% increase at the close. The company reported third-quarter GAAP net income of $11.4 million, or $0.11 per share, compared to a loss of $2.9 million, or $0.03 per share, last year. Adjusted EPS rose to $0.18 from $0.02. Net product sales reached $49.5 million, up from $28.7 million.
Assertio narrowed its full-year 2025 guidance, projecting net product sales between $110 million and $112 million, and adjusted EBITDA between $14 million and $16 million.
Abeona Therapeutics Inc. (ABEO) moved up 8.51% to $4.59 in after-hours trading. The company did not release news Monday but is scheduled to report third-quarter results on November 12. Analysts expect a loss of $0.34 per share on revenue of $5.53 million.
Analysen zu Abeona Therapeutics Inc
Um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Parker-Hannifin
✅ JPMorgan Chase
✅ Dollarama
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Bio-Techne Corp | 51.50 | 0.98% |
|
| Health Catalyst Inc Registered Shs | 2.32 | -0.85% |
|
| KalVista Pharmaceuticals Inc | 9.75 | -0.51% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Hoffen auf US-Zolldeal und absehbares Ende für Shutdown: SMI mit Gewinnen -- DAX weiter auf Erholungskurs -- Asiens Börsen schliessen mehrheitlich moderat höherAm heimischen Aktienmarkt sind zur Wochenmitte Gewinne zu sehen. Auch der Aktienmarkt in Deutschland zeigt sich auf grünem Terrain. In Fernost legten die Börsen zur Wochenmitte zu.